JDRF-funded researchers are using gene therapy in a promising approach to stopping the autoimmune attack that triggers type 1 diabetes (T1D). The gene therapy manipulates the body’s varied immune cells, which perform different functions. Some immune cells, called T-effector cells, attack foreign material in the body that may cause disease, whereas others, called T-regulatory cells, keep them in check.
↧